Clinical Trial Update: Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

View source ↗

Summary

Clinical trial update assessing short-term treatment satisfaction and quality of life in hidradenitis suppurativa patients initiated on secukinumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa | Status: ACTIVE_NOT_RECRUITING